Ipswich, MA, (November 03, 2006) – New England Biolabs, a leading manufacturer of molecular biology reagents has been approved for ISO 9001 certification by National Quality Assurance, USA. For New England Biolabs, the receipt of ISO 9001 certification, the most widely recognized international standard for quality management systems, is an important step in maintaining their leadership position in the industry.

"This is an important milestone for NEB," said James Ellard, CEO of New England Biolabs. "Our reputation as a leading provider of high quality products and outstanding customer service is further enhanced by achieving ISO certification. This is a clear sign that we are committed to continually improving our quality management systems in order to meet the needs of the evolving molecular biology, genomics and proteomics markets."

New England Biolabs received its ISO 9001 registration from National Quality Assurance, USA ( NQA, USA), an accredited registrar that performs assessments of management systems against requirements of national and international standards for quality. NQA, USA was chosen because of its broad industrial, manufacturing, and distribution expertise.

"New England Biolabs is now able to proudly display its ISO 9001 certificate. This is tangible evidence of their commitment to superior product quality and customer satisfaction," said Derek Coppinger, Business Development Manager of NQA, USA. "From the initial document review to the final assessment audit, New England Biolabs was a true pleasure to audit because of their strong company wide commitment to ISO 9001 registration and the direct benefit it would have for their customers."

New England Biolabs Quality Management System is applicable to the design, development, production and distribution of molecular biology reagents and related products for applications in academic institutions and industry as well as the OEM market. For more information contact Fiona Stewart, Ph.D., Business Development Manager at 978-380-7297 (stewart@neb.com) or visit our website at www.neb.com.

About New England Biolabs

New England Biolabs leads the industry in the discovery and production of enzymes for life science applications. Established in the mid-1970's, New England Biolabs now offers the largest selection of recombinant and native enzymes for DNA work, genomics and proteomics. NEB also supplies protein expression systems, competent cells and transfection reagents. New England Biolabs is a privately held company headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and four subsidiaries located in Canada, China, Germany and the UK.

About NQA, USA

NQA, USA, headquartered in Acton, Massachusetts, was established in 1992 as a joint venture between National Quality Assurance, Limited (headquartered in London, England) and National Technical Systems, Inc. (located in Calabasas, CA). It is a world-renowned ISO 9000, ISO 14001, QS-9000, AS9000, and TickIT registrar. NQA, USA’s single point of contact saves their clients time, while its well trained, efficient staff, located nationwide, provides local attention. NQA's worldwide operations are accredited to perform management systems registrations by ANSI/RAB (American National Standards Institute/Registrar Accreditation Board), UKAS (United Kingdom Accreditation Service), and RvA (Raad voor Accreditatie).

Additional information on NQA, USA is available at www.nqa-usa.com or contact the Business Development Department at 800-649-5289; fax 978-263-0785; e-mail sales@nqa-usa.com.

View NEB ISO 9001 Certificate.